These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7741262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K, Blanusa M, Piasek M, Jones MM, Singh PK.
    Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
    [Abstract] [Full Text] [Related]

  • 3. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K, Kargacin B, Blanusa M, Piasek M, Jones MM, Singh PK.
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [Abstract] [Full Text] [Related]

  • 4. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
    Kostial K, Blanusa M, Piasek M, Prester L, Jones MM, Singh PK.
    J Appl Toxicol; 1995 Sep; 15(3):201-6. PubMed ID: 7560740
    [Abstract] [Full Text] [Related]

  • 5. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
    Kostial K, Blanusa M, Piasek M, Simonović I, Jones MM, Singh PK.
    Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
    [Abstract] [Full Text] [Related]

  • 6. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
    Kostial K, Blanusa M, Piasek M, Restek-Samarzija N, Jones MM, Singh PK.
    J Appl Toxicol; 1999 Sep; 19(3):143-7. PubMed ID: 10362263
    [Abstract] [Full Text] [Related]

  • 7. Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid.
    Walker EM, Stone A, Milligan LB, Gale GR, Atkins LM, Smith AB, Jones MM, Singh PK, Basinger MA.
    Toxicology; 1992 Nov 22; 76(1):79-87. PubMed ID: 1335621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ascorbic acid supplementation does not improve efficacy of meso-dimercaptosuccinic acid treatment in lead-exposed suckling rats.
    Varnai VM, Piasek M, Blanusa M, Juresa D, Sarić M, Kostial K.
    Pharmacol Toxicol; 2003 Oct 22; 93(4):180-5. PubMed ID: 14629742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
    Bellés M, Sánchez DJ, Gómez M, Domingo JL, Jones MM, Singh PK.
    Toxicology; 1996 Jan 08; 106(1-3):93-7. PubMed ID: 8571406
    [Abstract] [Full Text] [Related]

  • 20. Mobilization of lead by calcium versenate and dimercaptosuccinate in the rat.
    Tandon SK, Singh S, Prasad S, Mathur N.
    Clin Exp Pharmacol Physiol; 1998 Sep 08; 25(9):686-92. PubMed ID: 9750957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.